Role of tissue kallikrein-kininogen-kinin pathways in the cardiovascular system

Archives of Medical Research

Volumn 37, Issue 3, 2006, Pages 299-306

  Sharma, Jagdish N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Angiotensin converting enzyme inhibitors; Cardiac diseases; Cardioprotection; Hypertension; Kallikrein kinin system

Indexed keywords

B 5630; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KALLIDIN; KALLIKREIN; KININ; KININOGEN; NIFEDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; DRUG ANTAGONISM; DRUG INHIBITION; GENE TARGETING; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; REVIEW;

ANIMALS; CARDIOVASCULAR SYSTEM; HEART DISEASES; HUMANS; KININOGENS; KININS; MODELS, BIOLOGICAL; TISSUE KALLIKREINS;

EID: 33644541745     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2005.08.001     Document Type: Review

References (97)

1. H.L. Nolly, and J. Brotis Kinin-forming enzyme in rat cardiac tissue Am J Physiol 265 1981 H1209 H1214
2. J.N. Sharma, and K. Uma Cardiac kallikrein in hypertensive and diabetic rats with and without diabetes Immunopharmacology 33 1996 341 343
3. J.N. Sharma, K. Uma, and A.P.M. Yusof Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats Int J Cardiol 63 1998 229 235
4. J.N. Sharma, K. Uma, and A.P.M. Yusof Altered cardiac tissue and plasma kininogen levels in hypertensive and diabetic rats Immunopharmacology 34 1999 129 132
5. N.B. Oza, and H.D. Goud Kininogenase of the aortic wall in spontaneously hypertensive rats J Cardiovasc Pharmacol 20 Suppl 9 1992 1 3
6. H.L. Nolly, O.A. Carretero, and A.J. Sclicli Kallikrein release by vascular tissue Am J Physiol 265 1993 H1209 H1214
7. A. Vegh, L. Szekeres, and J.R. Parratt Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmia in anaesthetized dogs Br J Pharmacol 104 1991 294 295
8. W. Linz, G. Wiemer, and B.A. Scholkens Bradykinin prevents left ventricular hypertrophy in rats J Hypertens 11 Suppl 5 1993 S96 S97
9. A. Vegh, J.G. Rapp, and J.R. Parratt Attenuation of the antiarrhythmic effects of ischaemia preconditioning by blocked of bradykinin B2 receptors Br J Pharmacol 107 1994 1167 1172
10. T.M. Walls, R. Sheehy, and J.C. Hartman Role of bradykinin in myocardial preconditioning J Pharmacol Exp Ther 270 1994 681 689
11. W.W. Linz, G. Wiemer, and B.A. Scholkens Contribution of bradykinin to the cardiovascular effects of ramipril J Cardiovasc Pharmacol 22 Suppl 9 1993 S1 S8
12. J.N. Sharma Kinin-forming system in the genesis of hypertension Agents Actions 14 1984 200 205
13. J.N. Sharma Interrelationship between the kallikrein-kinin system and hypertension: a review Gen Pharmacol 19 1988 177 187
14. J.N. Sharma Contribution of kinin system to the antihypertensive action of angiotensin converting enzyme inhibitors Adv Exp Med Biol 247A 1989 197 205
15. J.N. Sharma, K.K. Uma, and A.R. Noor Blood pressure regulation by the kallikrein-kinin system Gen Pharmacol 27 1996 55 63
16. J.N. Sharma Does kinin mediate the hypotensive action of angiotensin converting enzyme (ACE) inhibitors Gen Pharmacol 21 1990 451 457
17. J.N. Sharma Involvement of the kinin-forming system in physiopathology of rheumatoid inflammation Agents Actions 38 III 1992 343 361
18. T. Nagayasa, and S. Nagasawa Studies of human kininogen. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW) kininogen J Biochem 85 1979 249 258
19. W. Muller-Esterl, S. Iwanaga, and S. Nakanishi Kininogens revisited TIBS 11 1986 336 339
20. L.M. Greenbaum T-kinin and T-kininogen. Children of technology Biochem Pharmacol 33 1982 2943 2944
21. H. Okamoto, and L.M. Greenbaum Pharmacological properties of T-kinin Biochem Pharmacol 32 1983 2637 2638
22. K.K. Nustad, K. Vaaje, and J.V. Pierce Synthesis of kallikrein by rat kidney slices Br J Pharmacol 53 1975 229 234
23. J.N. Sharma, I.J. Zeitlin, S.D. Deodhar, and W.W. Buchanan Detection of tissue kallikrein-like activity in inflamed synovial tissue Arch Int Pharmacody Ther 262 1983 279 286
24. K.D. Bhoola, C.D. Figueroa, and K. Worth Bioregulation of kinin, kallikrein, kininogen and kininases Pharmacol Rev 44 1992 1 80
25. Y. Takada, R.A. Skidgel, and E.G. Erdos Purification of human urinary prokallikrein: identification of the site of activation by the metalloproteinase thermolysin Biochem J 232 1985 851 856
26. A.S. Weiss, J.L. Gallin, and A.P. Kaplan Fletcher factor deficiency: a diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity and kinin generation J Clin Invest 53 1974 622 633
27. C.G. Cochrane, S.D. Revak, and D. Wuepper Activation of Hageman factor in solid and fluid phase. A critical role of kallikrein J Exp Med 138 1973 1564 1583
28. J.H. Griffin, and C.G. Cochrane Mechanism for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor Proc Natl Acad Sci 73 1976 2554 2558
29. R. Mandle, R.W. Colman, and A. Kaplan Identification of prekallikrein and HMW- kininogen as a complex in human plasma Proc Natl Acad Sci 73 1976 4176 4183
30. R.E. Thampson, R. Mandle, and A.P. Kaplan Association of factor XI and high molecular weight kininogen in human plasma J Clin Invest 60 1977 1376 1380
31. M. Silverberg, and S. Diehl The autoactivation of factor XII (Hageman factor) induced by low-heparin and dextran sulfate Biochem J 248 1987 715 720
32. C. Woolly-Miller, J. Chao, and L. Chao Restriction fragment length polymorphism's mapped in spontaneously hypertensive rats using kallikrein probes J Hypertens 7 1989 865 871
33. M. Pravenc, V. Ken, J. Kunes, G. Sclicli, O.A. Carretero, L. Simonet, and T.W. Kurtz Cosegregation of blood pressure with a kallikrein gene family polymorphism Hypertension 17 1991 242 246
34. E.G. Erdos Some old and some new ideas on kinin metabolism J Cardiovasc Pharmacol 15 Suppl 6 1990 S20 S24
35. F. Marceau, J.F. Hess, and D.R. Bachvarov The Bl receptors for kinin Pharmacol Rev 50 1998 357 386
36. D. Regoli Neurohumoral regulation of precapillary vessels: the kallikrein-kinin system J Cardiovasc Pharmacol 6 Suppl 3 1984 S401 S412
37. P. D'Orleans-Juste, G. de Nussi, and J.R. Vane Kinins act on Bl or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells Br J Pharmacol 96 1989 920 926
38. C.W. Tiffany, and M. Burch Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages FEBS Lett 247 1989 189 192
39. E.T. Whalley, S. Clegg, J.M. Stewart, and R.J. Vavrek The effect of kinin agonists and antagonists on the pain response of human blister base Naunyn-Schmiedeberg's Arch Pharmacol 336 1987 652 655
40. J.N. Sharma, and A.P.M. Yusof Pro-inflammatory properties of the kallikrein-kinin system: potential for new drug therapy Inflammopharmacology 6 1998 289 296
41. J.N. Sharma, A.P.M. Yusof, and K.J. Wirth The kinin antagonist Hoe 140 reduce acute paw oedema in rats caused by carrageenan, bradykinin and kaolin Inflammopharmacology 6 1988 9 17
42. L.S. Jin, E. Seeds, C. Page, and M. Schachter Inhibition of bradykinin-induced bronchoconstriction in guinea-pig by a synthetic B2 receptor antagonist Br J Pharmacol 97 1989 598 602
43. J.N. Sharma, J.M. Stewart, S.S.J. Mohsin, M. Katori, and R. Vavrek Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats Agents Actions 38 III 1992 258 269
44. S.A. Abbas, J.N. Sharma, and A.P.M. Yusof Effect of bradykinin and its antagonist on survival time after coronary artery occlusion in rats Gen Pharmacol 33 1999 243 247
45. S.A. Abbas, J.N. Sharma, and A.P.M. Yusof The effect of bradykinin and its antagonist on survival time after coronary artery occlusion in hypertensive rats Immunopharmacology 44 1999 93 98
46. J. Barabe, J.N. Droulin, D. Regoli, and W.K. Park Receptors for bradykinin in intestine and uterine smooth muscle Can J Physiol Pharmacol 96 1977 920 926
47. S.G. Farmer, R.M. Burch, S.A. Meeker, and D.E. Wilkins Evidence for a pulmonary B3 bradykinin receptor Mol Pharmacol 36 1989 1 8
48. J.K. Saha, J.N. Sengupta, and R.K. Goyal Effect of bradykinin on opossum longitudinal smooth muscle: evidence for novel bradykinin receptors J Pharmacol Exp Ther 252 1990 1012 1020
49. J.K. Saha, J.N. Sengupta, and R.K. Goyal Effect of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor J Pharmacol Exp Ther 259 1991 265 273
50. D. Regoli, and J. Barabe Pharmacology of bradykinin and related kinins Pharmacol Rev 32 1980 1 46
51. K.J. Wirth, F.J. Hock, U. Albus, W. Linz, H.G. Alphermann, H. Anagnostopoulos, and B.A. Scholkens Hoe 140 a new potent and long acting bradykinin antagonist - in vitro studies Br J Pharmacol 102 1991 774 777
52. J.C. Cheronis, E.T. Whally, and K.T. Nguyen A new class of bradykinin antagonist: synthesis and in vitro activity of bissuccinimidoalkane peptide dimmers J Med Chem 35 1992 1563 1572
53. L. Hanson, R.G. McCullough, and W.M. Selig In vivo pharmacological profile of novel, potent, stable BK antagonist at B1 and B2 receptors Immunopharmacology 33 1996 191 193
54. G.M. Burgess, M.N. Perkins, P.R. Rang, E.A. Cambell, M.C. Brown, P. McIntyre, L. Urban, E.K. Dziadulewicz, T.J. Ritchie, A. Hallett, C.R. Snell, R. Wrigglesworth, W. Lee, C. Davis, S.B. Phagoo, A.J. Davis, E.P. Phillips, G.S. Darke, G.A. Hughes, A. Dusten, and G.C. Bloomfield Bradyzide, a potent non-peptide B2 bradykinin receptor antagonist with long-lasting oral activity in animal models of inflammatory hyperalgesia Br J Pharmacol 129 2000 77 86
55. S.G. Farmer, and R.M. Burch Biochemical and molecular pharmacology of kinin receptors Annu Rev Pharmacol Toxicol 32 1992 511 536
56. R.M. Burch Kinin signal transduction: role of phosphoinositides and eicosanoids J Cardiovasc Pharmacol 15 Suppl 6 1990 S44 S46
57. J.N. Sharma, and I.J. Zeitlin Indomethacin in low concentrations potentiates the action of some spasmogens on the isolated oestrous rat uterus J Pharm Pharmacol 29 1977 316 317
58. A. Akbar, J.N. Sharma, A.P.M. Yusof, and E.K. Gan Potentiation of bradykinin-induced responses in the intact and denuded epithelium of guinea pig tracheal preparations Tissue Reactions 20 1998 95 100
59. W. Ransom, G.S. Young, K. Schneck, and C.B. Goodman Characterization of solubilized bradykinin B2 receptors from smooth muscle and mucosa of guinea-pig ileum Biochem Pharmacol 43 1992 1823 1827
60. V.B. Schini, C. Boulanger, D. Regoli, and P.M. Vanhoutte Bradykinin stimulates the production of cyclic GMP via activation of B2 receptors in cultured porcine aortic endothelial cells J Pharmacol Exp Ther 252 1990 581 585
61. A. Adetuyibi, and I.H. Mills Relationship between urinary kallikrein and renal function, hypertension, and excretion of sodium and water in man Lancet 2 1972 203 207
62. F.M. De Freitas, E.Z. Farraco, and D.F. de Azevedo General circulatory alterations induced by intravenous infusion of synthetic bradykinin in man Circulation 29 1964 66 70
63. M.E. Webster, and J.P. Gilmore Influence of kallidin-10 on renal function Am J Physiol 206 1964 714 718
64. J.C. McGiff, H.D. Itskovitz, and N.A. Terrango The action of bradykinin and eledoicin in the canine isolated kidney: relationship to prostaglandins Clin Sci Mol Med 49 1975 125 131
65. H.S. Margolius, R. Geller, J.J. Pisano, and A. Sjoerdsma Altered urinary kallikrein excretion in human hypertension Lancet 2 1971 1063 1065
66. H.S. Margolius, R. Geller, W. deJong, J.J. Pisano, and A. Sjoerdsma Altered urinary kallikrein excretion in rats with hypertension Circ Res 30 1972 358 362
67. J.N. Sharma, and I.J. Zeitlin Altered plasma kininogen in clinical hypertension Lancet 1 1981 125 126
68. J.N. Sharma Kinin system and prostaglandins in the intestine Pharmacol Toxicol 63 1988 310 316
69. F.A. Almeida, R.C.R. Stella, A. Voos, H. Ajzen, and A.B. Riberio Malignant hypertension: a syndrome associated with low plasma kininogen and kinin potentiating factor Hypertension 3 1981 46 50
70. F.W. James, and V.H. Donaldson Decrease exercise tolerance and hypertension in serve hereditary deficiency of plasma kininogen Lancet 1 1981 889
71. Mohsin SSJ, Majima M, Katori M, Sharma JN. Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats. Asia Pacific J Pharmacol 992;71:73-82.
72. M. Katori, and M. Majima Role of the renal kallikrien-kinin system in the development of hypertension Immunopharmacology 36 1997 237 242
73. C. Wang, L. Chao, and J. Chao Human tissue kallikrein induces hypotension in transgenic mice Hypertension 23 1994 236 243
74. J.N. Sharma, S.S. Amrah, and A.R. Noor Suppression of hypotensive responses of captopril and enalapril by kallikrein inhibitors aprotinin in spontaneously hypertensive rats Pharmacology 50 1995 363 369
75. J. Chao, and L. Chao Kallikrein gene therapy in hypertension, cardiovascular and renal diseases Gen Ther Mol Biol 1 1998 301 308
76. K. Silberbauer, B. Stanek, and H. Temple Acute hypotensive effect of captopril in man modified by prostaglandian synthesis inhibition Br J Clin Pharmacol 14 1982 87S 93S
77. M. Antonaccio Angiotensin converting enzyme (ACE) inhibitors Annu Rev Pharmacol Toxicol 22 1982 57 87
78. J.N. Sharma, P.G. Ferandez, B.K. Kim, and C.R. Triggle Systolic blood pressure responses to enalapril maleate (MK 421), an angiotensin converting enzyme inhibitor and hydrochlorothiazide in conscious Dahl salt-sensitive (S) and salt-resistant (R) rats Can J Physiol Pharmacol 62 1984 241 243
79. H. Edery, T. Rosenthal, G. Amitzur, A. Rubinstein, and N. Stern The influence of SQ 20881 on the blood kinin system of renal hypertensive patients Drug Exp Clin Res VII 1981 749 756
80. C. Smith, S. Campbell, and J. Albano Urinary kallikrein excretion in normotensive and hypertensive pregnancies: 8 years later Immunopharmacology 44 1990 177 182
81. J.N. Sharma Therapeutic prospects of bradykinin antagonists Gen Pharmacol 24 1993 267 274
82. E. Braunwald Cardiovascular medicine at turn of the millennium: triumphs, concern and opportunities N Engl J Med 337 1997 1360 1369
83. W. Lochner, and J.R. Parratt A comparison of the effects of locally and systemically administered kinin on coronary blood flow and myocardial metabolism Br J Pharmacol Chemother 26 1966 17 26
84. W. Linz, G. Wiemer, and P. Gohlke Contribution of kinin to the cardiovascular action of converting-enzyme inhibitors Pharmacol Rev 47 1995 25 50
85. P. Zhu, C.E. Zugga, D. Simper, P. Hornstein, P.R. Allegrini, and P.T. Buser Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide and prostacyclin Cardiovasc Res 29 1995 658 663
86. P. Madeddu, A.F. Milia, M.B. Salis, L. Gaspa, W. Gross, A. Lippoldt, and G. Emanueli Renovascular hypertension in bradykinin B2-receptor knockout mice Hypertension 23 1998 305 509
87. M.R. Kichuck, N. Seyedi, X. Zhang, C.C. Marboe, R.E. Michler, L.J. Addonzio, G. Kaley, A. Nasjletti, and T.H. Hintze Regulation of nitric acid production in human coronary microvessels and the contribution of local kinin formation Circulation 94 1996 44 51
88. E.T. Whalley, J.A. Solomon, and D.M. Modafferi CP-0127, a novel potent bradykinin antagonist increases survival in rat and rabbit model of endotoxin shock Agents Actions 38 Suppl 1992 413 420
89. A. Koide, I.J. Zeitlin, and J.R. Parratt Kinin formation in ischaemic heart and aorta of anaesthetized rats J Physiol (Lond) 467 1993 125P
90. B.A. Scholkens Kinins in the cardiovascular system Immunopharmacology 33 1996 209 217
91. L.E. Rubin, and R. Levi Protective role of bradykinin in cardiac anaphylaxis Circ Res 79 1995 434 440
92. H. Yoshida, J.J. Zhang, L. Chao, and J. Chao Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischaemia and perfusion Hypertension 35 2000 25 31
93. J.N. Sharma, and U. Kesavarao Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats Pharmacology 64 2002 196 200
94. C.R. Dela, A. Suffredini, J.D. Page, R.A. Pixley, N. Kaufman, J.E. Parrillo, and R.W. Colman Activation of kallikrein-kinin system after endotoxin administration to normal human volunteers Blood 81 1993 3313 3317
95. A.S. Nies, R.P. Forsyth, H.E. Williams, and K.L. Melmon Contribution of kinins to endotoxin volunteers Blood 81 1993 3313 3317
96. S. Marcondes, and E. Antunes The plasma and tissue kininogen-kallikrein- kinin system: role in cardiovascular system Curr Med Chem 3 2005 33 44
97. R. Maestri, A.F. Milia, M.B. Salis, G. Graiani, C. Lagrasta, M. Monica, D. Corr, C. Emanueli, and P. Madeddu Cardiac hypertrophy and microvascular deficit in Kinin B2 receptor knockout mice Hypertension 41 2003 1151 1155